학술논문
Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia February 2024 24(2):105-121
Subject
Language
ISSN
2152-2650